Comprehensive University Study Notes on Neurotransmission and Receptors

Fundamentals of Neurotransmission

  • Neurotransmission is the comprehensive biological process where an action potential propagates down the length of an axon, triggering the release of neurotransmitters into the synaptic cleft, which subsequently bind to postsynaptic receptors to elicit postsynaptic effects.
  • Presynaptic axonal conductivity is unique within the neuron; the axon is the sole structural component of a neuron capable of conducting an action potential.
  • Postsynaptic response profile:
    • The ultimate physiological effect generated on the postsynaptic cell is determined primarily by the specific receptor type activated, rather than the intrinsic identity of the neurotransmitter molecule itself.
    • A single type of neurotransmitter can bind to multiple distinct receptor subtypes, yielding diverse physiological outcomes depending on the receptor distribution.
  • Synaptic integration and neuronal decision-making:
    • Individual neurons receive thousands of simultaneous synaptic inputs across their dendritic and somatic surfaces.
    • Neurons continuously integrate these incoming excitatory and inhibitory signals to determine whether or not to reach threshold and fire an action potential.
  • Axonal landmark definitions:
    • Axon Hillock: The specialized region at the junction between the soma and axon that serves as the initiation site for action potentials.
    • Axon Terminal: The distally distal end of an axon branch specialized for neurotransmitter synthesis, packaging, and presynaptic release.

Anatomical and Cellular Machinery of the Axon Terminal

  • Mitochondria density and energetic requirements:
    • Axon terminals contain exceptionally high concentrations of mitochondria.
    • Mitochondria supply local cellular energy exclusively in the form of adenosine triphosphate (ATPATP).
    • Powering vesicle priming, ion pumping, and enzymatic reactions requires substantial local ATPATP consumption; calling mitochondria the general "powerhouse" without detailing energetic functions is imprecise.
  • Presynaptic enzymatic activity:
    • Enzymes are specialized proteins that catalyze biological chemical reactions, including both anabolic synthesis and catabolic breakdown.
    • Enzymes responsible for neurotransmitter synthesis are heavily concentrated within the axon terminal cytoplasm.
  • Synaptic vesicles and transporter proteins:
    • Neurotransmitters are not freely floating loose within the presynaptic cytosol; uncontained diffusion would create extreme biochemical inefficiency.
    • Synaptic vesicles are lipid bilayer pockets that package and concentrate thousands of neurotransmitter molecules per individual vesicle.
    • Synaptic vesicle transporters are specialized transmembrane proteins that actively load and transport vesicular packages within the terminal cytosol.
  • Recycling and degradation systems:
    • Reuptake transporters are membrane-bound proteins engineered to clear neurotransmitters from the synaptic cleft and haul them back into the presynaptic terminal for direct repackaging and recycling.
    • Degradative enzymes break down un-recycled neurotransmitters within the cleft or terminal into precursor metabolites, which are subsequently resynthesized into active neurotransmitters.

Presynaptic Calcium Dynamics and Exocytosis

  • Step-by-step chemical synaptic transmission:
    • Neurotransmitters are synthesized in the cell body or presynaptic terminal and packaged into synaptic vesicles.
    • Vesicles are localized and held near the presynaptic release site.
    • Action potential propagation depolarizes the presynaptic membrane.
    • Depolarization triggers the opening of voltage-gated calcium channels.
    • Influx of calcium ions (Ca2+Ca^{2+}) into the terminal triggers vesicle fusion with the presynaptic membrane.
    • Neurotransmitters are extruded into the synaptic cleft via exocytosis.
    • Released molecules diffuse across the cleft and bind to postsynaptic receptors.
  • Mechanisms of calcium-driven release:
    • The action potential itself does not directly force neurotransmitter release; calcium entry is the mandatory causal intermediate.
    • Empirical experiments demonstrate that intracellular calcium elevation without prior membrane electrical activity is sufficient to induce exocytosis.
  • Biophysics of voltage-gated calcium channels:
    • Voltage-gated ion channels change conformation and open specifically in response to alterations in membrane electrical potential.
    • An action potential represents a rapid positive shift (depolarization) in membrane potential.
    • The equilibrium potential of calcium (ECaE_{Ca}) is approximately +123 mV+123\,\text{mV}.
    • During the peak of an action potential, the internal membrane potential sits at approximately +40 mV+40\,\text{mV} to +50 mV+50\,\text{mV}.
    • Because the resting or peak potential is far below +123 mV+123\,\text{mV}, an immense electrochemical driving force drives Ca2+Ca^{2+} rapidly inward upon channel opening.
  • Presynaptic Active Zone and SNARE protein complex:
    • Active Zone: The specialized presynaptic membrane site direct across from the postsynaptic density containing dedicated scaffolding proteins that dock and prime vesicles.
    • SNARE protein complex:
    • Vesicle SNAREs (v-SNAREsv\text{-SNAREs}) located on the synaptic vesicle membrane bind with Target SNAREs (t-SNAREst\text{-SNAREs}) on the presynaptic active zone plasma membrane.
    • This tethering interaction grounds the vesicle directly against the active zone membrane in a process known as synaptic docking.
    • Synaptotagmin is a specialized vesicle protein that acts as the intracellular Ca2+Ca^{2+} sensor; upon binding calcium, synaptotagmin catalyzes immediate lipid bilayer fusion.
    • Experimental disruption or genetic cleavage of SNARE proteins completely abolishes neurotransmitter release.

Vesicular Pool Dynamics and Endocytosis

  • Peptide synthesis and storage differences:
    • Peptides are large-chain protein neurotransmitters, whereas classical neurotransmitters are small amino acids or amines.
    • Peptides are packaged into secretory granules (large dense-core vesicles) rather than standard small synaptic vesicles.
    • Secretory granules reside further back from the active zone within the axon terminal cytoplasm.
    • Release kinetics: Peptides require high-frequency bursts of action potentials to build up sufficient, diffuse intracellular Ca2+Ca^{2+} concentrations to trigger secretory granule exocytosis, making peptide release slower than small-molecule exocytosis.
  • Functional vesicular pools:
    • Readily Releasable Pool (RRPRRP):
    • Vesicles docked directly at the active zone plasma membrane.
    • Mobilized and released immediately upon low-level Ca2+Ca^{2+} influx.
    • Reserve Pool:
    • Vesicles tethered to the cytoskeleton further away from the active zone, acting as functional backup reserves.
    • Mobilized only during intense, high-frequency action potential trains that induce sustained elevations in intracellular Ca2+Ca^{2+}.
  • Behavioral scaling of vesicular pools:
    • Consumption of small rewarding stimuli (e.g., a single piece of sour candy or a small sip of boba) triggers mild action potential firing, releasing dopamine strictly from the Readily Releasable Pool.
    • Massive over-indulgence (e.g., consuming three full boba drinks and a large bag of Sour Patch Kids) induces elevated action potential trains, raising intracellular Ca2+Ca^{2+} to recruit the Reserve Pool for massive dopamine discharge.
    • Hyper-elevated dopamine signals are translated by central circuits as aversive stimuli to prevent metabolic toxicity, inducing nausea or vomiting when physical thresholds are exceeded.
  • Endocytosis:
    • The active presynaptic process of retrieval and re-internalization of fused vesicular membrane components from the cell surface following exocytosis, allowing vesicles to be refilled with neurotransmitters.

Classification and Criteria of Neurotransmitters

  • Standard criteria to establish a chemical as a neurotransmitter:
    • The molecule must be synthesized and stored within the presynaptic neuron.
    • The molecule must be released by the presynaptic axon terminal upon stimulation by an action potential.
    • Exogenous experimental application of the substance must precisely mimic the endogenous postsynaptic response generated by presynaptic stimulation.
  • Major neurotransmitter chemical classes:
    • Amino Acids:
    • Small organic molecules containing an amino group and a carboxyl group; building blocks for proteins (which draw from 2222 standard biochemical amino acids).
    • Glutamate: The primary excitatory neurotransmitter in the central nervous system; ubiquitous across all regions of the brain.
    • γ\gamma-Aminobutyric Acid (GABAGABA): The primary inhibitory neurotransmitter in the brain; synthesized directly from its precursor, glutamate, via enzymatic cleavage.
    • Glycine: An inhibitory amino acid neurotransmitter active primarily in the spinal cord and brainstem.
    • Amines:
    • Serotonin (5-HT5\text{-HT}).
    • Acetylcholine (AChACh): Ubiquitously expressed across the central and peripheral nervous systems.
    • Dopamine (DADA).
    • Norepinephrine (NENE): Functions both as a central neurotransmitter and a peripheral stress hormone.
    • Epinephrine: Adrenaline; primarily synthesized by the adrenal glands sitting atop the kidneys and released into circulation as a endocrine hormone, with minor central neuronal expression.
    • Histamine.
    • Neuropeptides:
    • Cholecystokinin (CCKCCK): Regulates food intake and energy homeostasis.
    • Neuropeptide Y (NPYNPY): Modulates energy homeostasis and appetite regulation.
    • Vasoactive Intestinal Polypeptide (VIPVIP): Involved in central circuit modulation and arterial vasodilation.
  • Endocrine Hormones vs. Neurotransmitters:
    • Endocrine hormones are synthesized in peripheral glands or specialized structures and travel long distances through the circulatory system to hit target tissues, whereas neurotransmitters act across nanometer distances at the synaptic cleft.

Receptor Specificity and Pharmacological Modulation

  • Absolute lock-and-key receptor specificity:
    • Receptors exclusively bind their designated natural ligand or specific structural analogs.
    • A glutamate receptor will only bind glutamate.
    • GABAGABA can never bind to a glutamate receptor under any physiological conditions.
    • Monoamine receptors are strictly non-overlapping: Serotonin cannot bind to dopamine receptors despite both belonging to the monoamine chemical class.
  • Agonists vs. Antagonists:
    • Agonist: A chemical agent or drug that binds to a receptor and activates it, fully mimicking the physiological action of the endogenous neurotransmitter.
    • Cocaine acts as a powerful indirect dopamine agonist/enhancer, increasing synaptic dopamine concentration by 300 %300\,\% upon administration.
    • Morphine is a plant-derived alkaloid exogenous agonist that selectively binds to endogenous opioid receptors to induce profound analgesia.
    • Antagonist: A chemical agent or drug that binds to a receptor with high affinity but zero intrinsic activity, physically blocking the natural neurotransmitter from accessing its binding site.
    • Naloxone (Narcan) / Naltrexone: A high-affinity competitive antagonist at opioid receptors.
    • Mechanism of Overdose Reversal: Naloxone displaces full opioid agonists (such as fentanyl or heroin) from opioid receptors, immediately reversing respiratory depression and preventing fatal overdose outcomes.

Ligand-Gated Ion Channels, EPSPs, and IPSPs

  • Ligand-gated ion channels (Ionotropic Receptors):
    • Multimeric transmembrane channels that open directly upon the physical binding of a specific neurotransmitter (ligand).
    • Exhibits faster activation kinetics compared to metabotropic G-protein coupled receptors.
    • Generally less ion-selective than pure voltage-gated ion channels, often permitting the passage of multiple monovalent or divalent cation species.
    • Dominant in fast synaptic signaling driven by GABAGABA, glutamate, glycine, and acetylcholine.
  • Excitatory Postsynaptic Potentials (EPSPsEPSPs):
    • Transient postsynaptic membrane depolarization that brings the membrane potential closer to the action potential threshold.
    • Driven by Glutamate and Acetylcholine binding to ionotropic receptors.
    • Receptor activation triggers an influx of positive sodium ions (Na+Na^+) down their steep electrochemical gradient into the cell.
  • Inhibitory Postsynaptic Potentials (IPSPsIPSPs):
    • Transient postsynaptic membrane hyperpolarization that drives the membrane potential further away from the action potential threshold.
    • Driven by GABAGABA and Glycine binding to ionotropic receptors.
    • Receptor activation triggers an influx of negatively charged chloride ions (Cl−Cl^-) into the cell, taking the membrane potential down toward the chloride equilibrium potential.

Ionotropic Receptor Subtypes: Glutamate and GABA

  • Excitatory Glutamate Ionotropic Subtypes:
    • AMPAAMPA Receptor:
    • Glutamate-gated ion channel permeable to Na+Na^+ influx and K+K^+ efflux, but entirely impermeable to calcium (Ca2+Ca^{2+}).
    • Because the inward electrochemical driving force for Na+Na^+ heavily exceeds the outward force for K+K^+, net current flow is strongly inward, generating fast depolarization (EPSPsEPSPs).
    • NMDANMDA Receptor:
    • Glutamate-gated ion channel permeable to both Na+Na^+ and Ca2+Ca^{2+} entry, but impermeable to K+K^+.
    • Promotes excitatory depolarization along with intracellular calcium signaling cascades.
    • Kainate Receptor:
    • Glutamate-gated channel activated by kainic acid; hyper-activation by excess kainic acid or glutamate over-excitation drives uncontrolled seizure activity (epileptic fits).
  • Inhibitory GABAAGABA_A Receptors and Pharmacological Modulation:
    • Binding of GABAGABA opens integral Cl−Cl^- channels, hyperpolarizing the postsynaptic membrane.
    • Positional/Allosteric Modulators (Enhancers):
    • Benzodiazepines: Bind to distinct distinct allosteric sites on the GABAAGABA_A complex to increase the frequency of channel opening events, serving as effective anxiolytics.
    • Barbiturates: Bind to unique sites to prolong the total duration of channel open states.
    • Ethanol (Alcohol): Facilitates GABAGABA receptor opening, suppressing central nervous system activity and acting functionally as a legal self-medicated anxiolytic.
  • Physiological consequences of GABAGABA dysregulation:
    • Excessive GABAGABA activation: Over-inhibition suppresses global neuronal action potential firing, resulting in loss of consciousness, heavy sedation, and acute alcohol-induced blackouts.
    • Insufficient GABAGABA activity: Removal of central synaptic inhibition permits runaway excitatory firing from glutamate systems, causing severe epileptic seizures.

G-Protein Coupled Receptors (GPCRs) and Presynaptic Autoreceptors

  • Properties of Metabotropic GPCRs:
    • Far more abundant throughout the central nervous system than fast ligand-gated ion channels.
    • Signal through metabolic/enzymatic cascades requiring local energy expenditure (ATPATP).
    • Slower activation onset, but generate markedly longer-lasting, amplified biochemical effects across wide intracellular domains.
    • Over 800800 distinct GPCR genes exist in the human genome; acetylcholine alone acts on 55 distinct metabotropic subtypes, while glutamate binds 88 metabotropic subtypes (mGluR1mGluR1 through mGluR8mGluR8).
  • Presynaptic Autoreceptors:
    • Specialized GPCRs localized directly on the presynaptic axon terminal membrane rather than the postsynaptic density.
    • Function as a negative feedback homeostatic control mechanism: High concentrations of released neurotransmitter in the synaptic cleft bind presynaptic autoreceptors, signaling the presynaptic terminal to halt further exocytosis and synthesis.
  • GPCR Signal Transduction Mechanism:
    • In the inactive state, a heterotrimeric G-protein complex consists of α\alpha, β\beta, and γ\gamma subunits with guanine diphosphate (GDPGDP) bound to the α\alpha subunit.
    • Ligand binding induces a conformational change in the GPCR, activating the internal domain.
    • The receptor acts as a exchange factor, causing the α\alpha subunit to release GDPGDP and bind guanine triphosphate (GTPGTP).
    • α-GTP\alpha\text{-GTP} dissociates from the βγ\beta\gamma subunit complex.
    • Both functional units (α-GTP\alpha\text{-GTP} and βγ\beta\gamma) interact with downstream effectors:
    • Shortcut Pathway: Direct interaction with membrane ion channels (e.g., opening K+K^+ or closing Ca2+Ca^{2+} channels).
    • Second Messenger Cascade: Activation of membrane enzymes (such as adenylyl cyclase) to generate internal second messengers.
    • Signal termination occurs when the intrinsic GTPase activity of the α\alpha subunit hydrolyzes bound GTPGTP back to GDPGDP, inducing re-association of the inactive αβγ\alpha\beta\gamma heterotrimer.